Most Men With Prostate Cancer Can Avoid Or Delay Harsh Treatments, Long-Term Study Confirms

This study found that most men who avoided aggressive treatment for prostate cancer were no more likely to die from the disease than men who had surgery to remove the gland or who were treated with hormone blockers and radiation. Looking at this analysis another way, it provides a damning indictment regarding the ineffectiveness of conventional medicine in extending prostate cancer patients’ lives.

In contrast, research shows that science-based natural approaches to prostate cancer can slow down or even reverse the development of the disease. In a randomized placebo controlled trial, for example, men with precancerous lesions in their prostates took capsules containing 400 mg of the green tea extract epigallocatechin-3-gallate (EGCG) per day or a placebo. Carried out over a period of one year, the study found that the men who took EGCG experienced a significant decrease in levels of the cancer biomarker prostate-specific antigen (PSA). This is important as when assessed in combination with other key risk factors, high levels of PSA can indicate an increased risk of prostate cancer.

In a separate study, researchers in the United States have shown that taking vitamin D may slow down or reverse the progression of low-grade prostate cancer tumors. The patients who took part in the study were 37 men with prostate cancer who had decided to undergo prostatectomy (removal of the gland). Divided into two groups, they received either 4,000 IU of vitamin D per day or a placebo. After 60 days their prostate glands were removed and examined. The researchers found that the prostates of the men who had received the vitamin D supplements showed significant improvement, whereas the condition of those of the placebo group had either stayed the same or worsened.

To learn how prostate cancer can respond to Dr. Rath’s micronutrient synergy approach, see this article on our website.